Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVAGINALGeneric

VANOBID

CANDICIDIN

Standard Dose
0.6MG/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview VANOBID is listed in Drugs@FDA under application 061596 (ANDA).

Marketing status: Discontinued Active ingredient CANDICIDIN Form and strength OINTMENT;VAGINAL - 0.6MG/GM Sponsor SANOFI AVENTIS US Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview VANOBID is listed in Drugs@FDA under application 061596 (ANDA). Marketing status: Discontinued Active ingredient CANDICIDIN Form and strength OINTMENT;VAGINAL - 0.6MG/GM Sponsor SANOFI AVENTIS US Submission history See approval history documents.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
VANOBID (CANDICIDIN) | Drug Monograph | MedicHelpline